PATENT CLAIM ANALYSIS

Application Number: 16181628
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-05
Patent Classification: ["424", "001650"]

Abstract:
Among the various aspects of the present disclosure is the provision of compositions and methods for imaging and treating subjects with amyloidosis or multiple myeloma with or without amyloidosis.

Claim (Index 19):
The method of  claim 16 , wherein\n (i) a monomeric LC present in the biological sample serves as a substrate for amyloid fibril formation and rare AL amyloid particles seed amplification; or (ii) an amount of LC amyloid will be quantified from t lag  and from the detection of LC amyloid using an imaging agent according to  claim 1  fluorescence amplitude using as a reference scale synthetic seeds derived from fibril formation in vitro.

Metadata:
- Claim Count in Document: 49.0
- Percentile: 98.0
- Lexical Diversity: 1.30435
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13314160', '15026545', '12811049', '15552614', '15258883']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7130558486305139
- 35 USC 102 Novelty (BERT): 0.4809600993448248
- Combined Prediction Score: 0.689846273701945
- Mean Citation Score: 167.89954399999996
- Max Citation Score: 173.50372
- Similarity Product: 124.7462758804178

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test